- Home
- ACET vs FDSB Comparison
ACET vs FDSB Comparison
Compare ACET & FDSB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ACET
- FDSB
- Stock Information
- Founded
- ACET 1947
- FDSB 1926
- Country
- ACET United States
- FDSB United States
- Employees
- ACET N/A
- FDSB N/A
- Industry
- ACET Biotechnology: Pharmaceutical Preparations
- FDSB
- Sector
- ACET Health Care
- FDSB
- Exchange
- ACET Nasdaq
- FDSB NYSE
- Market Cap
- ACET 83.2M
- FDSB 72.0M
- IPO Year
- ACET N/A
- FDSB N/A
- Fundamental
- Price
- ACET $0.98
- FDSB $12.60
- Analyst Decision
- ACET Buy
- FDSB
- Analyst Count
- ACET 5
- FDSB 0
- Target Price
- ACET $5.67
- FDSB N/A
- AVG Volume (30 Days)
- ACET 1.6M
- FDSB 10.9K
- Earning Date
- ACET 03-18-2025
- FDSB 03-04-2025
- Dividend Yield
- ACET N/A
- FDSB N/A
- EPS Growth
- ACET N/A
- FDSB N/A
- EPS
- ACET N/A
- FDSB N/A
- Revenue
- ACET N/A
- FDSB $10,898,681.00
- Revenue This Year
- ACET N/A
- FDSB N/A
- Revenue Next Year
- ACET N/A
- FDSB N/A
- P/E Ratio
- ACET N/A
- FDSB N/A
- Revenue Growth
- ACET N/A
- FDSB N/A
- 52 Week Low
- ACET $0.81
- FDSB $9.85
- 52 Week High
- ACET $2.61
- FDSB $14.50
- Technical
- Relative Strength Index (RSI)
- ACET 57.01
- FDSB N/A
- Support Level
- ACET $0.84
- FDSB N/A
- Resistance Level
- ACET $1.04
- FDSB N/A
- Average True Range (ATR)
- ACET 0.08
- FDSB 0.00
- MACD
- ACET 0.01
- FDSB 0.00
- Stochastic Oscillator
- ACET 68.65
- FDSB 0.00
About ACET Adicet Bio Inc.
Adicet Bio Inc is a clinical-stage biotechnology company discovering and developing allogeneic gamma delta T cell therapies for cancer and other diseases. Its lead product candidate, ADI-001, a first-in-class allogeneic gamma delta T cell therapy expressing a CAR targeting CD20, is being developed for the potential treatment of autoimmune diseases and relapsed or refractory aggressive B cell non-Hodgkin's lymphoma. Their pipeline also includes its lead preclinical candidate, ADI-270, an armored gamma delta CAR T cell product candidate targeting renal cell carcinoma, with potential for other CD70+ solid tumor and hematological malignancies indications.
About FDSB FIFTH DISTRICT BANCORP INC.
Fifth District Bancorp inc is a holding company of Fifth District. Fifth District portfolio consists primarily of fixed-rate one- to four-family residential mortgage loans also originate construction loans, home equity loans, home equity lines of credit, land loans, and share loans (loans secured by deposit accounts at Fifth District) and purchase commercial business loans. The company offer a variety of deposit accounts including checking accounts, money market accounts, and certificates of deposit. In addition, it offers electronic banking services including mobile banking, on-line banking, telephone banking, bill pay, and electronic funds transfer via SmartPay..